InvestorsHub Logo
Followers 23
Posts 1033
Boards Moderated 0
Alias Born 05/22/2014

Re: Brian903 post# 52749

Monday, 09/26/2016 9:05:27 AM

Monday, September 26, 2016 9:05:27 AM

Post# of 144817
There is currently no treatment that is effective in slowing the production and accumulation of malignant ascites fluid in patients with abdominal cancers. So, along with the preparations currently being made to get into the P2b trial for pancreatic cancer, we're also conducting additional pre-clinical studies which will form the basis for a clinical trial in humans to show that PharmaCyte’s treatment can slow the production and accumulation of ascites in the abdominal cavity - and don't forget about diabetes clinical trials! The future of PMCB looks incredibly bright from where I sit!
Volume:
Day Range:
Bid:
Ask:
Last Trade Time:
Total Trades:
  • 1D
  • 1M
  • 3M
  • 6M
  • 1Y
  • 5Y
Recent PMCB News